Cancer Clinical Trial -Daiichi Sankyo-PL3397-A-U4003

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib (PLX3397)

Drug

Pexidartinib

Phase

Phase IV

Condition

Tenosynovial Giant Cell Tumor

Keywords

TURALIO PLX3397